Ginkgo Bioworks Holdings (DNA) Long-Term Investments (2021 - 2026)

Ginkgo Bioworks Holdings' Long-Term Investments history runs 6 years deep, the most recent figure standing at $14.7 million for Q1 2026.

• Quarterly Long-Term Investments fell 54.3% year-over-year to $14.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $14.7 million (down 54.3% YoY) and the FY2025 annual result came in at $15.1 million, down 69.07% from the prior year.
• Long-Term Investments was $14.7 million for Q1 2026 at Ginkgo Bioworks Holdings, down from $15.1 million in the prior quarter.
• Across five years, Long-Term Investments topped out at $103.0 million in Q1 2022 and bottomed at $1.1 million in Q2 2023.
• A 5-year average of $44.0 million and a median of $32.7 million in 2025 frame the typical range for Long-Term Investments.
• Annual changes were most pronounced in 2022 — Long-Term Investments surged 18274.13% — and 2023, when it sank 98.85%.
• Ginkgo Bioworks Holdings' Long-Term Investments stood at $1.5 million in 2022, then soared by 4991.7% to $78.6 million in 2023, then plunged by 38.01% to $48.7 million in 2024, then sank by 69.07% to $15.1 million in 2025, then declined by 2.41% to $14.7 million in 2026.
• Business Quant data shows DNA's Long-Term Investments at $14.7 million in Q1 2026, $15.1 million in Q4 2025, and $30.2 million in Q3 2025.